Allyson Guidroz Amedisys Inc (AMED) insider trading activity

Allyson Guidroz is Chief Accounting Officer of AMEDISYS INC. Currently has a direct ownership of 0 shares of AMED, which is worth approximately $0. The most recent transaction as insider was on Aug 14, 2025, when has been sold 9,472 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Allyson Guidroz Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 14 2025	SELL Sale (or disposition) back to the issuer	-	9,472 Reduced 100.0%	0 Common Stock
Aug 06 2025	BUY Grant, award, or other acquisition	-	2,015 Added 17.54%	9,472 Common Stock
Jul 25 2025	SELL Payment of exercise price or tax liability	$2,448 $97.94 p/Share	25 Reduced 0.33%	7,457 Common Stock
Jul 01 2025	SELL Payment of exercise price or tax liability	$44,431 $96.38 p/Share	461 Reduced 5.8%	7,482 Common Stock
Jun 01 2025	SELL Payment of exercise price or tax liability	$16,085 $94.07 p/Share	171 Reduced 2.11%	7,943 Common Stock
May 08 2025	SELL Open market or private sale	$35,904 $96.0 p/Share	374 Reduced 4.41%	8,114 Common Stock
May 03 2025	SELL Payment of exercise price or tax liability	$26,208 $96.0 p/Share	273 Reduced 3.12%	8,488 Common Stock
Mar 04 2025	SELL Open market or private sale	$187,833 $92.03 p/Share	2,041 Reduced 18.89%	8,761 Common Stock
Feb 16 2025	SELL Payment of exercise price or tax liability	$23,520 $92.6 p/Share	254 Reduced 2.3%	10,802 Common Stock
Feb 16 2025	BUY Grant, award, or other acquisition	-	2,160 Added 16.34%	11,056 Common Stock
Jul 31 2024	BUY Grant, award, or other acquisition	-	2,179 Added 19.67%	8,896 Common Stock
Jul 25 2024	SELL Payment of exercise price or tax liability	$9,970 $97.75 p/Share	102 Reduced 1.5%	6,717 Common Stock
Jun 01 2024	SELL Payment of exercise price or tax liability	$15,951 $91.15 p/Share	175 Reduced 2.5%	6,819 Common Stock
May 03 2024	SELL Payment of exercise price or tax liability	$26,058 $92.08 p/Share	283 Reduced 3.89%	6,994 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	2,143 Added 22.75%	7,277 Common Stock

Allyson Guidroz

Chief Accounting Officer

Baton Rouge, LA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMED shares.

Notify only if

Value

Insider Trading

Get notified when an Amedisys Inc insider buys or sells AMED shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMEDISYS INC

Track Activities on AMED

Account